From: Talcum powder or aqueous gel to aid external cephalic version: a randomised controlled trial
Powder n = 48 | Gel n = 47 | P value | Relative risk (95% confidence interval) | |
---|---|---|---|---|
Mean ± standard deviation, Median [interquartile range] or Number (%) | ||||
Primary outcome | ||||
ECV Related Maternal Pain VNRS* | 6 [5–9] | 8 [7–9] | P = 0.03 | |
6.9 ± 2.2 | 7.9 ± 1.7 | P = 0.02 | ||
ECV outcomes | ||||
First round of ECV (up to 2 attempts) † | P = 0.31 | RR 0.6 (95% CI 0.3–1.4) | ||
Successful | 21 (43.8) | 26 (55.3) | ||
Failed | 27 (56.2) | 21 (44.7) | ||
First round of ECV (up to 2 attempts) | ||||
First ECV attempt | P = 0.99 | RR 1.0 (95% CI 0.7–1.5) | ||
Successful | 20/48 (41.7) | 19/47 (40.4) | ||
Failed | 28/48 (58.3) | 28/47 (59.6) | ||
Second ECV attempt (failed 1st attempt) n = 56 | P = 0.07 | |||
Successful | 1/28 (3.6) | 7/28 (25.0) | ||
Failed | 23/28 (82.1) | 17/28 (60.7) | ||
Not attempted | 4/28 (14.3) | 4/28 (14.3) | ||
Second round of ECV (up to 2 attempts) | ||||
Crossed-over (after failed 1st round) n = 48 | To gel | To powder | P = 0.07 | RR 3.9 (95% CI 1.0–15) |
Yes | 13/27 (48.1) | 4/21 (19.0) | ||
No | 14/27 (51.9) | 17/21 (81.0) | ||
3rd ECV attempt (after cross-over) n = 17 | Using gel | Using powder | P = 0.99 | RR 0.8 (95% CI 0.1–6.0) |
Successful | 4/13 (30.8) | 1/4 (25.0) | ||
Failed | 9/13 (69.2) | 3/4 (75.0) | ||
4th ECV attempt (after failed 3rd attempt) n = 12 | Using gel | Using powder | P = 0.80 | |
Successful | 1/9 (11.1) | 0/3 (0.0) | ||
Failed | 2/9 (22.2) | 1/3 (33.3) | ||
Not attempted | 6/9 (66.7) | 2 /3(66.7) | ||
Cross-over round | P = 0.99 | RR 1.9 (95% CI 0.2–23) | ||
Successful | 5/13 (38.5) | 1/4 (25.0) | ||
Failed | 8/13 (61.5) | 3/4 (75.0) | ||
Powder | Gel | |||
Final ECV outcome (cross-over included)‡ | P = 0.84 | RR 0.9 (95% CI 0.4–2.0) | ||
Successful | 26 (54.2) | 27 (57.4) | ||
Failed | 22 (45.8) | 20 (42.6) |